0001950047-24-000492.txt : 20240129 0001950047-24-000492.hdr.sgml : 20240129 20240129160841 ACCESSION NUMBER: 0001950047-24-000492 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240129 DATE AS OF CHANGE: 20240129 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CRISPR Therapeutics AG CENTRAL INDEX KEY: 0001674416 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 473173478 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-37923 FILM NUMBER: 24573716 BUSINESS ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 BUSINESS PHONE: 6173154600 MAIL ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Kulkarni Samarth CENTRAL INDEX KEY: 0001682019 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O CRISPR THERAPEUTICS AG STREET 2: 200 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 144 1 primary_doc.xml 144 0001682019 XXXXXXXX LIVE 0001674416 CRISPR THERAPEUTICS AG 001-37923 Baarerstrasse 14 Zug V8 6300 41 (0)41 561 32 77 SAMARTH KULKARNI Officer Director Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 38th Floor New York NY 10004

50000 3025570.00 79432446 01/29/2024 NASDAQ Common 01/29/2024 Stock Option Exercise Issuer N 50000 01/29/2024 Cash N SAMARTH KULKARNI

Baarerstrasse 14 Zug V8 6300

Common 01/16/2024 20000 1250056.00 01/29/2024 09/15/2023 /s/ Samarth Kulkarni